This article explores the transformative potential of integrating radiomics and digital pathology (pathomics) in oncology.
Foundation models, large-scale deep learning models pre-trained on vast datasets through self-supervised learning, are revolutionizing the discovery of cancer imaging biomarkers.
The integration of Artificial Intelligence (AI) into Clinical Decision Support Systems (CDSS) promises to revolutionize healthcare by enhancing diagnostic precision and personalized treatment.
This article provides a comprehensive overview of the transformative role of machine learning (ML) in cancer risk prediction and prognosis, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive overview of the transformative role of Artificial Intelligence (AI) in precision oncology for researchers, scientists, and drug development professionals.
This systematic review synthesizes the current landscape of machine learning (ML) applications in oncology, addressing its transformative potential across the cancer care continuum.
This article provides a comprehensive benchmark comparison between pharmacophore-based virtual screening (PBVS) and high-throughput screening (HTS) for researchers and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on applying Receiver Operating Characteristic (ROC) curve analysis to evaluate pharmacophore model performance.
This article provides a comprehensive guide for researchers and drug development professionals on integrating Molecular Dynamics (MD) simulations into the pharmacophore model validation pipeline.
This article provides a systematic guide for researchers and drug development professionals on optimizing pharmacophore model sensitivity—a critical parameter for successful virtual screening.